Explore the benefits of the Precision GLP-1 agonist, a new therapy that improves glycaemic control and reduces side effects.

Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.

Could targeting a enzyme play a role in slowing lung fibrosis? Boehringer Ingelheim’s research into PDE4B is offering ...

Discover how circular RNA technology enhances gene expression by up to 50-fold in eye treatments, surpassing traditional ...

Explore how tuberculosis bacteria survive within human cells, revealing potential paths for new treatments against this ...

Learn how animal-free 3D systems can reduce variability in drug discovery, leading to better human biology representation.

The researchers identified seven driver genes responsible for tumour development when mutated. The most common was FBXW7, altered in over half of feline mammary tumours. In human breast cancer, ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

PBS293-MMAE targets EGFR and EphA2, two proteins shown to be co-expressed in colorectal cancer cells. While EGFR is a clinically validated target in colorectal cancer, therapeutic antibodies such as ...

Explore how HPV tumours are targeted by innovative vaccine designs that enhance immune response against cancer effectively.

Discover the groundbreaking research on organoid models for spinal cord injury, promising new therapies for paralysis recovery.

Explore the latest research on rare liver cancer and how a new drug may enable effective immunotherapy treatments.